Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Lassen

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Journal of Thrombosis and Haemostasis : JTH|January 3, 2013
Apixaban after hip or knee arthroplasty versus enoxaparin: efficacy and safety in key clinical subgroupsG F Pineo, A S Gallus, G E Raskob, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 1, 1992
Reduction of plasma levels of prothrombin fragments 1 and 2 during thromboprophylaxis with a low-molecular-weight heparinJ V Sørensen, M R Lassen, L C Borris, et al.
Alimentary Pharmacology & Therapeutics|April 15, 2004
Low molecular weight heparin (tinzaparin) vs. placebo in the treatment of mild to moderately active ulcerative colitisS Bloom, S Kiilerich, M R Lassen, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|November 1, 1993
Haemostatic activation in patients with head injury with and without simultaneous multiple traumaJ V Sørensen, H P Jensen, H B Rahr, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1991
Clinical trials with low molecular weight heparins in the prevention of postoperative thromboembolic complications: a meta-analysisM R Lassen, L C Borris, H M Christiansen, et al.
Journal of Thrombosis and Haemostasis : JTH|August 1, 2007
A dose escalation study of YM150, an oral direct factor Xa inhibitor, in the prevention of venous thromboembolism in elective primary hip replacement surgeryB I Eriksson, A G G Turpie, M R Lassen, et al.
Thrombosis Research|July 1, 1991
Components of coagulation and fibrinolysis during thrombosis prophylaxis with a low molecular weight heparin (Enoxaparin) versus Dextran 70 in hip arthroplastyL C Borris, J V Sørensen, M R Lassen, et al.
The Journal of Bone and Joint Surgery. British Volume|May 2, 2009
Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacementB I Eriksson, A K Kakkar, A G G Turpie, et al.
Journal of Thrombosis and Haemostasis : JTH|October 1, 2004
Bilateral vs. ipsilateral venography as the primary efficacy outcome measure in thromboprophylaxis clinical trials: a systematic reviewA Y Y Lee, M Gent, J A Julian, et al.
The Bone & Joint Journal|March 30, 2013
Extended venous thromboembolism prophylaxis in patients undergoing hip fracture surgery - the SAVE-HIP3 studyW D Fisher, G Agnelli, D J George, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Journal of Thrombosis and Haemostasis : JTH|January 3, 2013
Apixaban after hip or knee arthroplasty versus enoxaparin: efficacy and safety in key clinical subgroupsG F Pineo, A S Gallus, G E Raskob, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 1, 1992
Reduction of plasma levels of prothrombin fragments 1 and 2 during thromboprophylaxis with a low-molecular-weight heparinJ V Sørensen, M R Lassen, L C Borris, et al.
Alimentary Pharmacology & Therapeutics|April 15, 2004
Low molecular weight heparin (tinzaparin) vs. placebo in the treatment of mild to moderately active ulcerative colitisS Bloom, S Kiilerich, M R Lassen, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|November 1, 1993
Haemostatic activation in patients with head injury with and without simultaneous multiple traumaJ V Sørensen, H P Jensen, H B Rahr, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1991
Clinical trials with low molecular weight heparins in the prevention of postoperative thromboembolic complications: a meta-analysisM R Lassen, L C Borris, H M Christiansen, et al.
Journal of Thrombosis and Haemostasis : JTH|August 1, 2007
A dose escalation study of YM150, an oral direct factor Xa inhibitor, in the prevention of venous thromboembolism in elective primary hip replacement surgeryB I Eriksson, A G G Turpie, M R Lassen, et al.
Thrombosis Research|July 1, 1991
Components of coagulation and fibrinolysis during thrombosis prophylaxis with a low molecular weight heparin (Enoxaparin) versus Dextran 70 in hip arthroplastyL C Borris, J V Sørensen, M R Lassen, et al.
The Journal of Bone and Joint Surgery. British Volume|May 2, 2009
Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacementB I Eriksson, A K Kakkar, A G G Turpie, et al.
Journal of Thrombosis and Haemostasis : JTH|October 1, 2004
Bilateral vs. ipsilateral venography as the primary efficacy outcome measure in thromboprophylaxis clinical trials: a systematic reviewA Y Y Lee, M Gent, J A Julian, et al.
The Bone & Joint Journal|March 30, 2013
Extended venous thromboembolism prophylaxis in patients undergoing hip fracture surgery - the SAVE-HIP3 studyW D Fisher, G Agnelli, D J George, et al.
Pageof 7